These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19763839)

  • 1. Multivariate data analysis as a semi-quantitative tool for interpretive evaluation of comparability or equivalence of aerodynamic particle size distribution profiles.
    Shi S; Hickey AJ
    AAPS PharmSciTech; 2009; 10(4):1113-20. PubMed ID: 19763839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.
    Christopher D; Adams W; Amann A; Bertha C; Byron PR; Doub W; Dunbar C; Hauck W; Lyapustina S; Mitchell J; Morgan B; Nichols S; Pan Z; Singh GJ; Tougas T; Tsong Y; Wolff R; Wyka B
    AAPS PharmSciTech; 2007 Nov; 8(4):E90. PubMed ID: 18181550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: part 2--evaluation of a method for determining equivalence.
    Christopher D; Adams WP; Lee DS; Morgan B; Pan Z; Singh GJ; Tsong Y; Lyapustina S
    AAPS PharmSciTech; 2007 Jan; 8(1):5. PubMed ID: 17408228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitivity analysis of the modified chi-square ratio statistic for equivalence testing of aerodynamic particle size distribution.
    Weber B; Lee SL; Lionberger R; Li BV; Tsong Y; Hochhaus G
    AAPS J; 2013 Apr; 15(2):465-76. PubMed ID: 23344791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade Impactor Equivalence Testing: Comparison of the Performance of the Modified Chi-Square Ratio Statistic (mCSRS) with the Original CSRS and EMA's Average Bioequivalence Approach.
    Kurumaddali A; Christopher D; Sandell D; Strickland H; Morgan B; Bulitta J; Wiggenhorn C; Stein S; Lyapustina S; Hochhaus G
    AAPS PharmSciTech; 2019 Jul; 20(6):249. PubMed ID: 31286316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stability analysis of a modified version of the chi-square ratio statistic: implications for equivalence testing of aerodynamic particle size distribution.
    Weber B; Hochhaus G; Adams W; Lionberger R; Li B; Tsong Y; Lee SL
    AAPS J; 2013 Jan; 15(1):1-9. PubMed ID: 23008161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the modified chi-square ratio statistic in a stepwise procedure for cascade impactor equivalence testing.
    Weber B; Lee SL; Delvadia R; Lionberger R; Li BV; Tsong Y; Hochhaus G
    AAPS J; 2015 Mar; 17(2):370-9. PubMed ID: 25515206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
    Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Sensitivity and Robustness of Modified Chi-Square Ratio Statistic for Cascade Impactor Equivalence Testing Through Monte Carlo Simulations.
    Kurumaddali A; Christopher D; Strickland H; Morgan B; Wiggenhorn C; Stein S; Lyapustina S; Hochhaus G
    AAPS PharmSciTech; 2020 May; 21(5):147. PubMed ID: 32435854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 1: background for a statistical method.
    Adams WP; Christopher D; Lee DS; Morgan B; Pan Z; Singh GJ; Tsong Y; Lyapustina S
    AAPS PharmSciTech; 2007 Jan; 8(1):4. PubMed ID: 17408227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals.
    Tougas TP; Goodey AP; Hardwell G; Mitchell J; Lyapustina S
    AAPS PharmSciTech; 2017 Feb; 18(2):451-461. PubMed ID: 27068528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2019 Jan; 20(2):57. PubMed ID: 30623259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
    David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
    AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs).
    Tougas TP; Christopher D; Mitchell JP; Strickland H; Wyka B; Van Oort M; Lyapustina S
    AAPS PharmSciTech; 2009; 10(4):1276-85. PubMed ID: 19882251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates.
    Yoshida H; Kuwana A; Shibata H; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2017 Apr; 18(3):646-653. PubMed ID: 27173989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs.
    Mitchell JP; Stein SW; Doub W; Goodey AP; Christopher JD; Patel RB; Tougas TP; Lyapustina S
    AAPS PharmSciTech; 2019 May; 20(5):206. PubMed ID: 31147791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS).
    Doub W; Stein S; Mitchell J; Goodey AP
    AAPS PharmSciTech; 2020 Aug; 21(7):239. PubMed ID: 32827121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
    Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
    AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.
    Devadason SG; Chan HK; Haeussermann S; Kietzig C; Kuehl PJ; Newman S; Sommerer K; Taylor G
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S6-9. PubMed ID: 23215848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.